| 0 |
Echinocandin Antifungal [EPC] |
5 |
0.0006 |
| 1 |
Asparagine-specific Enzyme [EPC] |
6 |
0.0004 |
| 2 |
Lipid-based Polyene Antifungal [EPC] |
5 |
0.0004 |
| 3 |
Azole Antifungal [EPC] |
32 |
0.0002 |
| 4 |
Antimetabolite Immunosuppressant [EPC] |
4 |
0.0002 |
| 5 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
4 |
0.0002 |
| 6 |
Allylamine Antifungal [EPC] |
1 |
0.0001 |
| 7 |
Polyene Antifungal [EPC] |
5 |
0.0001 |
| 8 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
16 |
0.0001 |
| 9 |
Aminoglycoside Antibacterial [EPC] |
4 |
0.0001 |
| 10 |
Penem Antibacterial [EPC] |
3 |
0.0001 |
| 11 |
Bile Acid [EPC] |
2 |
0.0001 |
| 12 |
Folate Analog Metabolic Inhibitor [EPC] |
26 |
0.0001 |
| 13 |
Macrolide Antimicrobial [EPC] |
3 |
0.0001 |
| 14 |
Antirheumatic Agent [EPC] |
6 |
0.0001 |
| 15 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 16 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 17 |
Interleukin-6 Receptor Antagonist [EPC] |
7 |
0.0001 |
| 18 |
Vitamin D3 Analog [EPC] |
1 |
0.0000 |
| 19 |
BCL-2 Inhibitor [EPC] |
3 |
0.0000 |
| 20 |
Nucleoside Analog Antiviral [EPC] |
4 |
0.0000 |
| 21 |
Nitroimidazole Antimicrobial [EPC] |
3 |
0.0000 |
| 22 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Alkylating Drug [EPC] |
10 |
0.0000 |
| 24 |
Nucleoside Metabolic Inhibitor [EPC] |
11 |
0.0000 |
| 25 |
Fluoroquinolone Antibacterial [EPC] |
5 |
0.0000 |
| 26 |
Androgen [EPC] |
1 |
0.0000 |
| 27 |
Iron Chelator [EPC] |
1 |
0.0000 |
| 28 |
CD20-directed Cytolytic Antibody [EPC] |
10 |
0.0000 |
| 29 |
Purine Antimetabolite [EPC] |
3 |
0.0000 |
| 30 |
Corticosteroid [EPC] |
36 |
0.0000 |
| 31 |
Protease Inhibitor [EPC] |
1 |
0.0000 |
| 32 |
Janus Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 33 |
Cytochrome P450 3A Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Anti-epileptic Agent [EPC] |
3 |
0.0000 |
| 35 |
Kinase Inhibitor [EPC] |
7 |
0.0000 |
| 36 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 37 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 38 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
0.0000 |
| 39 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 40 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 41 |
Proton Pump Inhibitor [EPC] |
5 |
0.0000 |
| 42 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 43 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 44 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 45 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 46 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 47 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 48 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |
| 49 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |